PCI Biotech: US patent for the vaccine technology (fimaVACC) in combination with checkpoint inhibitors Guest UserMay 31, 2021
PCI Biotech receives Orphan Drug Designation in South Korea for fimaporfin in the treatment of bile duct cancer Guest UserMay 28, 2021
OliX Pharmaceuticals and PCI Biotech announce a collaboration to combine OliX asiRNA and PCI Biotech fimaNAc technologies Guest UserMay 5, 2021
PCI Biotech: First US patient enrolled in the fimaCHEM pivotal RELEASE study Guest UserApril 30, 2021
PCI Biotech - release of the RNA Therapeutics Virtual Conference presentation Guest UserFebruary 10, 2021
PCI Biotech: Successful Phase I fimaVACC vaccination proof of concept study to be published in Frontiers in Immunology Guest UserNovember 23, 2020
PCI Biotech: European patent for treatment of bile duct cancer with the fimaCHEM technology Guest UserNovember 16, 2020
